German, Alexander https://orcid.org/0000-0002-8708-6809
Grotemeyer, Alexander https://orcid.org/0000-0002-9185-257X
Koller, Katharina https://orcid.org/0009-0007-4541-0811
Eckstein, Markus https://orcid.org/0000-0001-5418-3349
Wolff, Hannes https://orcid.org/0009-0003-3497-1796
Rampp, Stefan https://orcid.org/0000-0002-4826-1520
Süß, Patrick https://orcid.org/0000-0001-6926-1813
Müller, Vincent C. https://orcid.org/0000-0002-4144-4957
Birnbacher, Dieter
Winkler, Jürgen https://orcid.org/0000-0003-0630-9204
Regensburger, Martin https://orcid.org/0000-0002-2172-7386
Funding for this research was provided by:
Universitätsklinikum Erlangen
Article History
Received: 6 February 2026
Accepted: 6 August 2026
First Online: 1 September 2026
Declarations
Ethics approval and consent to participate: The study was conducted in accordance with the Declaration of Helsinki. The protocol for Structural Brain Preservation and biobanking was approved by the Institutional Review Board of Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany (Clinical trial numberApproval No. 23-416-B, issued February 29, 2024).
Consent for publication: Written informed consent was obtained from the patient for publication.
Competing interests: A.Ger. is a co-founder of Hiber GmbH since 2026, a company which aims to provide Structural Brain Preservation services in cooperation with academic partners. The case reported herein occurred in 2024. H.W. is a Legal Research Officer at the German Federal Constitutional Court; the opinions expressed herein are his own, he does not represent the Court, and the opinions do not reflect those of the Court. The remaining authors declare that they have no competing interests.